Oroxcell is regularly inspected by the ANSM (French Authorities) for performing regulatory toxicity studies for both pharmaceutical and cosmetic industries with a GLP compliant status.

Oroxcell has been granted from the French Ministry of Higher Education, Research and Innovation the approval to benefit Research Tax Credit (CIR). A tax credit for our R&D support (up to 30% ) can be applied to our customers.

The development organotypic three-dimensional models of Human tissues and organs has dramatically changed the mindset of testing innovative products in Industries, not only for efficacy, but also for investigating their ADME and toxicological properties.

Since 2006, Oroxcell, has built a strong experience in experimenting and validating series of assays based on 3D human tissues and organs. No doubt this trend is going to expand sharply during next decade.

Since 2004, Oroxcell has developed skills and capacities to cultivate cells for ADMET and efficacy testing.

Bioanalysis is an essential part in drug, discovery and development. Bioanalysis is related to the analysis of analytes (drugs, metabolites, biomarkers) in biological samples and it involves several steps from sample collection to sample analysis and data reporting.

Since 2004, Oroxcell proposes a strong analytical support to a wide range of biological studies, with offers spanning from screening to GLP compliant studies.